A two-dimensional iron-doped carbon-based nanoenzyme with catalase-like activity for the detection of alkaline phosphatase and ascorbate oxidase

Zhixuan Han,Qingjie Fu,Yuntai Lv,Nan Wang,Xingguang Su,Yuntai lv
DOI: https://doi.org/10.1016/j.talanta.2024.125704
IF: 6.1
2024-05-01
Talanta
Abstract:Herein, we successfully synthesized two-dimensional iron-doped carbon-based nanosheets (Fe-N<sub>800</sub> CS) with catalase-like activity through doping Fe into Zn MOF and introducing graphitic C<sub>3</sub>N<sub>4</sub> (g-C<sub>3</sub>N<sub>4</sub>). The interaction of the Fe-N<sub>800</sub> CS with hydrogen peroxide could generated abundant reactive oxygen species (ROS) and further oxidize o-Phenylenediamine (OPD) to 2,3-diaminophenazine (DAP) which has constant fluorescence at 560 nm. Ascorbic acid (AA) could be generated via the hydrolysis reaction between alkaline phosphatase (ALP) and ascorbic acid 2-phosphate (AAP). AA can be oxidized to dehy-droascorbic acid (DHA) by ROS, and then combined with OPD to generate 3-(1,2-dihydroxyethyl)furo[3,4b]-quinoxaline (QXD) with fluorescence at 440 nm, which could increase as the concentration of AA enhanced. DHA could also be generated through oxidation of AA by ascorbate oxidase (AAO). Thus, by monitoring the fluorescence ratio (I<sub>560</sub>/I<sub>440</sub>), a ratiometric fluorescence biosensing platform for ALP and AAO was established with the linear ranges in 0.2-10 U/L and 1-60 U/L, respectively. The limit of detection for ALP and AAO were 0.12 U/L and 0.59 U/L. Furthermore, the biosensing platform was successfully applied for the detection of ALP and AAO activity in human serum samples. This work provides a potential tool for future biomedical diagnostics.
chemistry, analytical
What problem does this paper attempt to address?
This paper aims to develop a two - dimensional iron - doped carbon - based nanozyme (Fe–N800 CS) with catalase - like activity, and construct a ratiometric fluorescence biosensing platform through this nanozyme for simultaneously detecting the activities of alkaline phosphatase (ALP) and ascorbate oxidase (AAO). Specifically, the research has solved the following problems: 1. **Developing a new nanozyme**: By incorporating iron into a zinc - metal - organic framework (Zn MOF) and introducing graphitic carbon nitride (g - C3N4), a two - dimensional iron - doped carbon - based nanosheet (Fe–N800 CS) with catalase - like activity was successfully synthesized. 2. **Establishing a ratiometric fluorescence biosensing platform**: Utilizing the reaction between Fe–N800 CS and hydrogen peroxide to generate a large number of reactive oxygen species (ROS), which then oxidize o - phenylenediamine (OPD) to generate 2,3 - diaminophenazine (DAP) with a fluorescence at 560 nm. Ascorbic acid (AA) can be generated through an alkaline phosphatase - catalyzed reaction and is oxidized to dehydroascorbic acid (DHA) by ROS or ascorbate oxidase. DHA then reacts with an excess of OPD to generate 3-(1,2 - dihydroxyethyl)furo[3,4b] - quinoxaline (QXD) with a fluorescence at 440 nm. By monitoring the fluorescence ratio (I560/I440), a ratiometric fluorescence biosensing platform for simultaneously detecting the activities of ALP and AAO was established. 3. **Improving detection sensitivity and selectivity**: This platform has high sensitivity to ALP and AAO in the linear ranges of 0.2–10 U/L and 1–60 U/L respectively, with detection limits of 0.12 U/L and 0.59 U/L respectively. In addition, this platform also shows good selectivity and anti - interference ability in actual samples (such as human serum). 4. **Application prospects**: This research provides a potential tool for future biomedical diagnosis, especially in the detection of ALP - and AAO - related diseases in clinical diagnosis. In conclusion, through developing a new nanozyme and constructing a ratiometric fluorescence biosensing platform, this paper has solved the problem of simultaneously and efficiently detecting the activities of ALP and AAO with high sensitivity, providing a new method for the diagnosis of related diseases.